» Articles » PMID: 2639727

Exploring Multidrug Resistance Using Rhodamine 123

Overview
Journal Cancer Commun
Specialty Oncology
Date 1989 Jan 1
PMID 2639727
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Accumulation of the dye rhodamine 123 was characterized by fluorescence in murine leukemia P388 cells and the Adriamycin-resistant subline, P388/ADR. Dye uptake by P388 cells was a slow, temperature-sensitive process, and involved binding at relatively hydrophobic and heterogeneous loci. Dye uptake by P388/ADR cells was temperature-insensitive, a steady state was quickly achieved, and the fluorescence emission spectrum suggested a relatively hydrophilic dye-binding site. Treatment of P388/ADR cells with verapamil resulted in enhanced accumulation of dye at hydrophobic loci. The fluorescence studies suggest that this dye may not reach the cytoplasm of P388/ADR cells, a result which may have implications with regard to the mechanism of multidrug resistance.

Citing Articles

PG-Priming Enhances Doxorubicin Influx to Trigger Necrotic and Autophagic Cell Death in Oral Squamous Cell Carcinoma.

Lin S, Weng C J Clin Med. 2018; 7(10).

PMID: 30347872 PMC: 6210351. DOI: 10.3390/jcm7100375.


From taxuspine x to structurally simplified taxanes with remarkable p-glycoprotein inhibitory activity.

Castagnolo D, Contemori L, Maccari G, Avramova S, Neri A, Sgaragli G ACS Med Chem Lett. 2014; 1(8):416-21.

PMID: 24900226 PMC: 4007961. DOI: 10.1021/ml100118k.


BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123.

de Lange E, De Bock G, Schinkel A, De Boer A, Breimer D Pharm Res. 1998; 15(11):1657-65.

PMID: 9833984 DOI: 10.1023/a:1011988024295.


P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.

Licht T, Pastan I, Gottesman M, Herrmann F Ann Hematol. 1994; 69(4):159-71.

PMID: 7948302 DOI: 10.1007/BF02215949.


Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.

Reichle A, Diddens H, Altmayr F, Rastetter J, Andreesen R Cancer Chemother Pharmacol. 1994; 34(4):307-16.

PMID: 7913420 DOI: 10.1007/BF00686038.